Showing results (191-200 of 206) with videos related to

Sort By:
Pageof 21
Hepatology Communications|February 5, 2024
Improved outcomes after hypothermic oxygenated machine perfusion in liver transplantation-Long-term follow-up of a multicenter randomized controlled trialZoltan Czigany, Deniz Uluk, Sandra Pavicevic, et al.
JHEP Reports : Innovation in Hepatology|April 17, 2025
Serum proteomics of adults with acute liver failure provides mechanistic insights and attractive prognostic biomarkersKatharina Remih, Franziska-Maria Hufnagel, Anna Sophie Karl, et al.
Orphanet Journal of Rare Diseases|April 9, 2026
Z variant heterozygosity in alpha-1 antitrypsin deficiency: disease risk and treatment implicationsCraig P Hersh, Jeffrey H Teckman, Pavel Strnad, et al.
Hepatology (Baltimore, Md.)|February 20, 2016
Canonical NF-κB signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein responseYoshiaki Sunami, Marc Ringelhan, Enikö Kokai, et al.
Nature Communications|July 8, 2022
Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironmentKai Markus Schneider, Antje Mohs, Wenfang Gui, et al.
Annals of Surgery|August 2, 2021
Hypothermic Oxygenated Machine Perfusion Reduces Early Allograft Injury and Improves Post-transplant Outcomes in Extended Criteria Donation Liver Transplantation From Donation After Brain Death: Results From a Multicenter Randomized Controlled Trial (HOPE ECD-DBD)Zoltan Czigany, Johann Pratschke, Jiří Froněk, et al.
Frontiers in Cell and Developmental Biology|June 22, 2026
Transcriptomic profiling of epigenetic regulators and metabolic reprogramming in human cholangiocarcinomaAmaya Lopez-Pascual, Jasmin Elurbide, Emiliana Valbuena-Goiricelaya, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 3, 2025
Mutational Analysis of Bile Cell-Free DNA in Primary Sclerosing Cholangitis: A Pilot StudyMaria Arechederra, Emil Bik, Carla Rojo, et al.
Gastroenterology|July 4, 2024
Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA)Virginia C Clark, Charlie Strange, Pavel Strnad, et al.
Translational Oncology|November 16, 2018
High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer PhenotypeNicole Golob-Schwarzl, Kira Bettermann, Anita Kuldeep Mehta, et al.
Pageof 21